KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Inventory: 2009-2024

Historic Change in Inventory for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to $24.5 million.

  • Emergent BioSolutions' Change in Inventory fell 2.22% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year increase of 238.38%. This contributed to the annual value of $24.5 million for FY2024, which is 4183.33% up from last year.
  • Emergent BioSolutions' Change in Inventory amounted to $24.5 million in FY2024, which was up 4,183.33% from -$600,000 recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Change in Inventory registered a high of $66.9 million during FY2020, and its lowest value of -$600,000 during FY2023.
  • For the 3-year period, Emergent BioSolutions' Change in Inventory averaged around $27.0 million, with its median value being $24.5 million (2024).
  • Per our database at Business Quant, Emergent BioSolutions' Change in Inventory slumped by 101.05% in 2023 and then soared by 4,183.33% in 2024.
  • Emergent BioSolutions' Change in Inventory (Yearly) stood at $66.9 million in 2020, then dropped by 0.45% to $66.6 million in 2021, then decreased by 14.26% to $57.1 million in 2022, then crashed by 101.05% to -$600,000 in 2023, then surged by 4,183.33% to $24.5 million in 2024.